ӳ��ý

Publications

Glucose-lowering drugs and liver-related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population-based studies.

Khanmohammadi S, Habibzadeh A, Kamrul-Hasan ABM, Schuermans A, Kuchay MS. Glucose-lowering drugs and liver-related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population-based studies. Diabetic medicine : a journal of the British Diabetic Association. 2024:e15437. doi:10.1111/dme.15437

Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues.

Hassan MM, Der Li Y, Ma MW, et al. Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues. European journal of medicinal chemistry. 2024;279:116904. doi:10.1016/j.ejmech.2024.116904

Circulating tumor DNA predicts venous thromboembolism in patients with cancers.

Ma S, Jiang JY, Kim RB, et al. Circulating tumor DNA predicts venous thromboembolism in patients with cancers. Journal of thrombosis and haemostasis : JTH. 2024. doi:10.1016/j.jtha.2024.09.009

Deconstructing inflammatory memory across tissue setpoints using cell circuit motifs.

Kwong AC, Ordovas-Montanes J. Deconstructing inflammatory memory across tissue setpoints using cell circuit motifs. The Journal of allergy and clinical immunology. 2024. doi:10.1016/j.jaci.2024.09.014

Integration of Transcriptomics, Proteomics and Loss-of-function Screening Reveals WEE1 as a Target for Combination with Dasatinib against Proneural Glioblastoma.

Alhalabi OT, Göttmann M, Gold MP, et al. Integration of Transcriptomics, Proteomics and Loss-of-function Screening Reveals WEE1 as a Target for Combination with Dasatinib against Proneural Glioblastoma. Cancer letters. 2024:217265. doi:10.1016/j.canlet.2024.217265

Corrigendum to "Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway" [Cancer Lett. 444 (2019) 82-93].

Wang J, Zhang N, Han Q, et al. Corrigendum to "Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway" [Cancer Lett. 444 (2019) 82-93]. Cancer letters. 2024:217257. doi:10.1016/j.canlet.2024.217257

A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders.

Lee AS, Ayers LJ, Kosicki M, et al. A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders. Nature communications. 2024;15(1):8268. doi:10.1038/s41467-024-52463-7

Vitessce: integrative visualization of multimodal and spatially resolved single-cell data.

Keller MS, Gold I, McCallum C, Manz T, Kharchenko P V, Gehlenborg N. Vitessce: integrative visualization of multimodal and spatially resolved single-cell data. Nature methods. 2024. doi:10.1038/s41592-024-02436-x

Taxometer: Improving taxonomic classification of metagenomics contigs.

Kutuzova S, Nielsen M, Piera P, Nissen JN, Rasmussen S. Taxometer: Improving taxonomic classification of metagenomics contigs. Nature communications. 2024;15(1):8357. doi:10.1038/s41467-024-52771-y

Blood-based DNA methylation and exposure risk scores predict PTSD with high accuracy in military and civilian cohorts.

Wani AH, Katrinli S, Zhao X, et al. Blood-based DNA methylation and exposure risk scores predict PTSD with high accuracy in military and civilian cohorts. BMC medical genomics. 2024;17(1):235. doi:10.1186/s12920-024-02002-6